MCID: PLC001
MIFTS: 44

Placenta Accreta malady

Categories: Fetal diseases

Aliases & Classifications for Placenta Accreta

Aliases & Descriptions for Placenta Accreta:

Name: Placenta Accreta 12 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4744
ICD10 33 O43.21
MeSH 42 D010921
NCIt 47 C26856
SNOMED-CT 64 70129008
UMLS 69 C0032044

Summaries for Placenta Accreta

Disease Ontology : 12 A placenta disease that is characterized by an abnormally deep attachment of the placenta, through the endometrium and into the myometrium.

MalaCards based summary : Placenta Accreta is related to placenta praevia and madras motor neuron disease. An important gene associated with Placenta Accreta is ANGPT2 (Angiopoietin 2), and among its related pathways/superpathways are ERK Signaling and PEDF Induced Signaling. The drugs Tranexamic Acid and Coagulants have been mentioned in the context of this disorder. Affiliated tissues include placenta, uterus and endothelial, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 71 Placenta accreta occurs when all or part of the placenta attaches abnormally to the myometrium (the... more...

Related Diseases for Placenta Accreta

Diseases related to Placenta Accreta via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 59)
id Related Disease Score Top Affiliating Genes
1 placenta praevia 10.1
2 madras motor neuron disease 10.1 ANGPT1 ANGPT2
3 isolated plagiocephaly 10.1 FLT1 PGF
4 common variable immunodeficiency 10.1 ANGPT1 TEK
5 pleural tuberculosis 10.1 FLT1 PGF
6 mucoepidermoid esophageal carcinoma 10.1 ANGPT1 TEK
7 alcoholic hepatitis 10.0 ANGPT2 SERPINB2 SERPINE1
8 vaginitis 10.0
9 cervicitis 10.0
10 asherman's syndrome 10.0
11 intermediate malignant teratoma 10.0 EGFR FLT1
12 radiation induced angiosarcoma of the breast 10.0 ANGPT1 ANGPT2 TEK
13 vesiculobullous skin disease 10.0 KDR TEK
14 kidney osteogenic sarcoma 10.0 FLT1 KDR
15 acute proliferative glomerulonephritis 10.0 FLT1 PGF SERPINE1
16 uterine inversion 9.9
17 endotheliitis 9.9
18 tricuspid valve prolapse 9.9 EGFR KDR
19 oppositional defiant disorder 9.9 KDR PGF TEK
20 ophthalmia neonatorum 9.9 FLT1 PGF
21 ovarian disease 9.9 FLT1 KDR
22 subdural empyema 9.8 FLT1 KDR TEK
23 vernal conjunctivitis 9.8 ANGPT2 FLT1 KDR
24 human granulocytic anaplasmosis 9.8 FLT1 KDR TEK
25 neuropathy with hearing impairment 9.8 FLT1 KDR PGF
26 benign familial neonatal epilepsy 9.8 EGFR KDR
27 mitral valve stenosis 9.8 FLT1 KDR
28 welander distal myopathy 9.8 FLT1 PGF SERPINB2 SERPINE1
29 thymus adenosquamous carcinoma 9.8 FLT1 KDR PGF
30 achromatopsia 9.8 ANGPT1 ANGPT2 FLT1 PGF
31 wolff-parkinson-white syndrome 9.8
32 sickle cell anemia 9.8
33 pulmonary hypertension 9.8
34 chorioamnionitis 9.8
35 thrombosis 9.8
36 disseminated intravascular coagulation 9.8
37 gestational diabetes 9.8
38 uterine disease 9.8
39 gestational trophoblastic neoplasm 9.8
40 choriocarcinoma 9.8
41 placental site trophoblastic tumor 9.8
42 trophoblastic neoplasm 9.8
43 syphilis 9.8
44 pulmonary embolism 9.8
45 myotonic dystrophy 9.8
46 partial hydatidiform mole 9.8
47 ganglioneuroblastoma 9.8 EGFR KDR
48 cleft palate cardiac defect ectrodactyly 9.8 EGFR KDR SERPINE1
49 localized junctional epidermolysis bullosa, non-herlitz type 9.8 ANGPT1 ANGPT2 FLT1 SERPINB2
50 mucinous ovarian cystadenoma 9.8 ANGPT1 KDR TEK

Graphical network of the top 20 diseases related to Placenta Accreta:



Diseases related to Placenta Accreta

Symptoms & Phenotypes for Placenta Accreta

MGI Mouse Phenotypes related to Placenta Accreta:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.06 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
2 homeostasis/metabolism MP:0005376 10.02 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
3 growth/size/body region MP:0005378 10.01 FLT1 KDR PGF SERPINB2 SERPINE1 TEK
4 immune system MP:0005387 9.92 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
5 embryo MP:0005380 9.91 ANGPT1 EGFR FLT1 KDR PGF TEK
6 mortality/aging MP:0010768 9.86 KDR SERPINB2 SERPINE1 TEK ANGPT1 ANGPT2
7 muscle MP:0005369 9.63 ANGPT1 EGFR FLT1 KDR SERPINB2 TEK
8 respiratory system MP:0005388 9.35 ANGPT2 EGFR KDR PGF SERPINE1
9 vision/eye MP:0005391 9.17 FLT1 KDR PGF TEK ANGPT1 ANGPT2

Drugs & Therapeutics for Placenta Accreta

Drugs for Placenta Accreta (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tranexamic Acid Approved Phase 4,Phase 3 1197-18-8 5526
2 Coagulants Phase 4,Phase 3
3 Hemostatics Phase 4,Phase 3
4 Antifibrinolytic Agents Phase 4,Phase 3
5
Mannitol Approved, Investigational Phase 3 69-65-8 453 6251
6 penicillins Phase 3
7 Anesthetics Phase 3
8 Pharmaceutical Solutions Phase 3
9
Progesterone Approved, Vet_approved 57-83-0 5994
10 Protective Agents
11 Antioxidants
12 acivicin
13 Hormones
14 Estrogens

Interventional clinical trials:

(show all 28)
id Name Status NCT ID Phase
1 Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study Recruiting NCT02806024 Phase 4
2 Tranexamic Acid in Adherent Placenta (TAP) Not yet recruiting NCT02329756 Phase 3
3 Balloon Tamponade for Atonic Primary Postpartum Hemorrhage Unknown status NCT02430155 Phase 2
4 Emergency Peripartum Hysterectomy: A Prospective Study in Iran Completed NCT01285258 Phase 2
5 Correlation Between PIF Maternal Serum Levels and Pregnancy Outcome Unknown status NCT01805102
6 ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta). Unknown status NCT02270593
7 Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population Completed NCT02302573
8 TUI 3D in Diagnosis of Placenta Accreta: Comparison With Gray-scale and Color Doppler Techniques Completed NCT02712099
9 Balloon Catheters in Cases of Abnormal Placentation Completed NCT01373255
10 Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta Completed NCT02966197
11 Long Term Comparison of Two Different Techniques of Uterine Cesarean Incision Closure Completed NCT01289262
12 The Effectiveness of Double Incision Technique in Uterus Preserving Surgery for Placenta Percreta Completed NCT02702024
13 Internal Iliac Artery Ligation and Abnormally Invasive Placenta Completed NCT02728232
14 Optimization of the Healing Process of the Uterine Scar Tissue After Re-cesarean Section Completed NCT02703519
15 Early Prediction of Placenta Accreta by Ultrasound and Color Doppler Recruiting NCT03032770
16 Antenatal Diagnosis of Placental Attachment Disorders Recruiting NCT02442518
17 Uterine Cavity and Blood Flow After Conservative Management of Placenta Previa/Accreta Recruiting NCT02878187
18 The Cervix as a Natural Tamponade in Postpartum Hemorrhage Caused by Placenta Previa and Placenta Previa Accreta Recruiting NCT02590484
19 Impact of Double-layer Versus Single-layer Uterine Closure Suture in Cesarean Section on the Development of Postoperative Uterine Scar Deficiency Recruiting NCT03039803
20 Clinical Situations at High Risk of Placenta Accreta / Percreta Active, not recruiting NCT02010229
21 Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta Active, not recruiting NCT02784886
22 Use of ROTEM Intraoperatively in Women With Placenta Accreta Enrolling by invitation NCT02729974
23 Placenta Accreta&Its Complications in Placenta Previa Cases Not yet recruiting NCT02606474
24 Transverse B-Lynch in Management of Placenta Accreta Not yet recruiting NCT02943421
25 Bilateral Internal Iliac Artery Ligation Before Cesarean Hysterectomy Not yet recruiting NCT03129035
26 Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial Not yet recruiting NCT02635412
27 Predictors of Scar Dehiscence in Patients With Previous Caesarean Section Not yet recruiting NCT03140683
28 Fertility Post Placenta Accrete Not yet recruiting NCT02821702

Search NIH Clinical Center for Placenta Accreta

Cochrane evidence based reviews: placenta accreta

Genetic Tests for Placenta Accreta

Anatomical Context for Placenta Accreta

MalaCards organs/tissues related to Placenta Accreta:

39
Placenta, Uterus, Endothelial, Testes, Heart, Cervix

Publications for Placenta Accreta

Articles related to Placenta Accreta:

(show top 50) (show all 491)
id Title Authors Year
1
MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls. ( 27762597 )
2017
2
Pathologically Diagnosed Placenta Accreta and Hemorrhagic Morbidity in a Subsequent Pregnancy. ( 28079779 )
2017
3
Relationship between first trimester aneuploidy screening test serum analytes and placenta accreta. ( 28027672 )
2017
4
Moving from intra partum to prenatal diagnosis of placenta accreta: a quarter of a century in the making but still a long road to go. ( 28009123 )
2017
5
Exposure to air pollutants during the early weeks of pregnancy, and placenta praevia and placenta accreta in the western part of Japan. ( 27164555 )
2016
6
EP14.03: Ultrasound diagnosis and evaluation of the number of prior Caesarean deliveries as risk factor for placenta accreta in placenta previa cases. ( 27646844 )
2016
7
Direct puncture embolization of the internal iliac artery during cesarean delivery for pernicious placenta previa coexisting with placenta accreta. ( 27634053 )
2016
8
Downregulation of miR-29a/b/c in placenta accreta inhibits apoptosis of implantation site intermediate trophoblast cells by targeting MCL1. ( 27871464 )
2016
9
Prenatal diagnosis of a true umbilical cord knot in a fetus with intrauterine growth restriction and placenta accreta. ( 27590396 )
2016
10
Escalating placenta invasiveness: repeated placenta accreta at the limit of viability. ( 27143953 )
2016
11
Placenta accreta and anesthesia: A multidisciplinary approach. ( 27375391 )
2016
12
High-intensity focused ultrasound combined with hysteroscopic resection to treat retained placenta accreta. ( 27668209 )
2016
13
Uterine Artery Embolization for Management of Primary Postpartum Hemorrhage Associated with Placenta Accreta. ( 28065219 )
2016
14
Comment on "Retained Placenta Accreta Mimicking Choriocarcinoma". ( 26933514 )
2016
15
Sclerotherapy with 6% polidocanol solution in patients with placenta accreta. ( 27751411 )
2016
16
Prophylactic bilateral internal iliac artery balloon occlusion in the management of placenta accreta: A 36-month review. ( 27495883 )
2016
17
Hysterectomy for placenta accreta; methods for gross and microscopic pathology examination. ( 26758078 )
2016
18
Caesarean hysterectomy for placenta accreta: paracervix should be divided sequentially, not en masse. ( 27129744 )
2016
19
Correlation of probability scores of placenta accreta on magnetic resonance imaging with hemorrhagic morbidity. ( 27687389 )
2016
20
Placenta accreta as a cause of peripartum hysterectomy. ( 27075384 )
2016
21
Placenta accreta following hysteroscopic myomectomy. ( 27398192 )
2016
22
Comparison of temporary abdominal aortic occlusion with internal iliac artery occlusion for patients with placenta accreta - a non-randomised prospective study. ( 27598045 )
2016
23
Can venous ProBNP levels predict placenta accreta? ( 26864469 )
2016
24
The recurrence risk of placenta accreta following uterine conserving management. ( 26836817 )
2016
25
Unusual imaging findings of placenta accreta resulting in early hysterectomy in first trimester-Two case reports. ( 28040150 )
2016
26
Reply to Letter to the Editor: attempted placental separation for suspected placenta accreta: experience may matter. ( 27061050 )
2016
27
Successful Management of Two Cases of Placenta Accreta and a Literature Review: Use of the B-Lynch Suture and Bilateral Uterine Artery Ligation Procedures. ( 27354921 )
2016
28
Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta. ( 26992667 )
2016
29
Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. ( 26901321 )
2016
30
Suspected placenta accreta and cesarean hysterectomy: observational cohort utilizing an intraoperative decision strategy. ( 26802252 )
2016
31
Attempted placental separation for suspected placenta accreta: experience may matter. ( 26947056 )
2016
32
Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. ( 27806657 )
2016
33
Cryopreserved embryo transfer isA anA independent risk factor forA placenta accreta. ( 25747133 )
2015
34
Placenta accreta: review and 3 case reports. ( 26117981 )
2015
35
Anesthetic management of placenta accreta in a low-resource setting: a case series. ( 26343175 )
2015
36
The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin. ( 25904157 )
2015
37
Pre-delivery remifentanil infusion for placenta accreta cesarean delivery under general anesthesia: an observational study. ( 26527226 )
2015
38
A Case Report and Literature Review of Midtrimester Termination of Pregnancy Complicated by Placenta Previa and Placenta Accreta. ( 26199801 )
2015
39
A challenging case of pregnancy with placenta accreta and very rare irregular antibodies versus Cromer blood group system: a case report. ( 25975935 )
2015
40
Ultrasound imaging of placenta accreta with MR correlation. ( 25622051 )
2015
41
Utility of ultrasound and magnetic resonance imaging in prenatal diagnosis of placenta accreta: A prospective study. ( 26752827 )
2015
42
Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. ( 26244528 )
2015
43
High-Intensity Focused Ultrasound treatment of placenta accreta after vaginal delivery: a preliminary study. ( 25846712 )
2015
44
Feasibility and safety of prophylactic uterine artery catheterization and embolization in the management of placenta accreta. ( 25533451 )
2015
45
Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? ( 25957019 )
2015
46
Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. ( 25751202 )
2015
47
Is the cold loop hysteroscopic technique a myometrial sparing treatment for placenta accreta residuals in a puerperal uterus? ( 26212585 )
2015
48
Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention. ( 26722586 )
2015
49
Placenta Accreta and Total Placenta Previa in the 19th Week of Pregnancy. ( 26366004 )
2015
50
Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta. ( 26135782 )
2015

Variations for Placenta Accreta

Expression for Placenta Accreta

Search GEO for disease gene expression data for Placenta Accreta.

Pathways for Placenta Accreta

Pathways related to Placenta Accreta according to GeneCards Suite gene sharing:

(show all 39)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.61 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
2
Show member pathways
13.42 ANGPT1 ANGPT2 EGFR FLT1 KDR TEK
3
Show member pathways
13.3 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
4
Show member pathways
13.15 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
5
Show member pathways
13.11 EGFR FLT1 KDR PGF TEK
6
Show member pathways
13.1 ANGPT1 ANGPT2 SERPINB2 SERPINE1 TEK
7
Show member pathways
13.06 EGFR FLT1 KDR PGF TEK
8
Show member pathways
13.01 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
9
Show member pathways
12.86 EGFR FLT1 KDR PGF
10
Show member pathways
12.85 EGFR FLT1 KDR PGF
11
Show member pathways
12.78 EGFR FLT1 KDR TEK
12
Show member pathways
12.71 EGFR FLT1 KDR PGF
13
Show member pathways
12.51 EGFR FLT1 KDR PGF
14
Show member pathways
12.41 ANGPT1 ANGPT2 EGFR TEK
15
Show member pathways
12.34 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
16
Show member pathways
12.32 EGFR FLT1 KDR
17
Show member pathways
12.26 EGFR FLT1 KDR
18 12.25 EGFR FLT1 KDR
19
Show member pathways
12.21 EGFR FLT1 KDR
20
Show member pathways
12.21 EGFR FLT1 KDR PGF
21
Show member pathways
12.05 ANGPT1 ANGPT2 TEK
22
Show member pathways
12.05 EGFR FLT1 KDR
23 12.03 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF
24
Show member pathways
12.01 EGFR FLT1 KDR TEK
25 11.87 ANGPT2 EGFR FLT1 KDR TEK
26
Show member pathways
11.71 FLT1 KDR PGF
27 11.69 ANGPT1 FLT1 TEK
28 11.61 ANGPT2 FLT1 KDR TEK
29
Show member pathways
11.57 EGFR FLT1 KDR
30 11.36 EGFR SERPINB2
31
Show member pathways
11.29 EGFR KDR
32 11.25 ANGPT1 ANGPT2 SERPINE1
33 11.22 ANGPT1 TEK
34 11.18 FLT1 KDR SERPINE1
35 11.1 ANGPT1 ANGPT2 EGFR FLT1 SERPINE1 TEK
36 11.04 ANGPT2 SERPINE1
37 10.94 ANGPT1 FLT1 KDR TEK
38
Show member pathways
10.81 FLT1 KDR PGF
39 10.7 SERPINB2 SERPINE1

GO Terms for Placenta Accreta

Cellular components related to Placenta Accreta according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.86 ANGPT1 ANGPT2 EGFR FLT1 KDR SERPINB2
2 extracellular space GO:0005615 9.5 ANGPT1 ANGPT2 EGFR FLT1 PGF SERPINB2
3 membrane raft GO:0045121 9.46 ANGPT1 EGFR KDR TEK
4 extracellular region GO:0005576 9.28 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF

Biological processes related to Placenta Accreta according to GeneCards Suite gene sharing:

(show all 34)
id Name GO ID Score Top Affiliating Genes
1 cell differentiation GO:0030154 9.98 ANGPT1 ANGPT2 FLT1 KDR PGF
2 phosphorylation GO:0016310 9.95 EGFR FLT1 KDR TEK
3 protein phosphorylation GO:0006468 9.94 EGFR FLT1 KDR TEK
4 negative regulation of apoptotic process GO:0043066 9.91 ANGPT1 EGFR KDR SERPINB2 TEK
5 positive regulation of cell proliferation GO:0008284 9.9 EGFR FLT1 KDR PGF
6 MAPK cascade GO:0000165 9.83 ANGPT1 EGFR TEK
7 leukocyte migration GO:0050900 9.82 ANGPT1 ANGPT2 TEK
8 positive regulation of cell migration GO:0030335 9.8 EGFR FLT1 KDR
9 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.8 ANGPT1 EGFR KDR TEK
10 response to hypoxia GO:0001666 9.79 ANGPT2 PGF TEK
11 protein autophosphorylation GO:0046777 9.78 EGFR FLT1 KDR TEK
12 positive regulation of protein phosphorylation GO:0001934 9.77 EGFR KDR TEK
13 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.77 ANGPT1 EGFR FLT1 KDR TEK
14 peptidyl-tyrosine phosphorylation GO:0018108 9.76 EGFR FLT1 KDR TEK
15 positive regulation of protein kinase B signaling GO:0051897 9.75 ANGPT1 EGFR TEK
16 vascular endothelial growth factor receptor signaling pathway GO:0048010 9.73 FLT1 KDR PGF
17 positive regulation of endothelial cell proliferation GO:0001938 9.72 KDR PGF TEK
18 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.71 ANGPT1 FLT1 KDR TEK
19 positive regulation of endothelial cell migration GO:0010595 9.7 ANGPT1 KDR TEK
20 animal organ regeneration GO:0031100 9.66 ANGPT2 PGF
21 peptidyl-tyrosine autophosphorylation GO:0038083 9.66 EGFR KDR
22 positive regulation of phosphatidylinositol 3-kinase activity GO:0043552 9.64 FLT1 TEK
23 blood vessel morphogenesis GO:0048514 9.63 ANGPT2 FLT1
24 positive regulation of focal adhesion assembly GO:0051894 9.62 KDR TEK
25 cellular response to vascular endothelial growth factor stimulus GO:0035924 9.61 FLT1 KDR
26 fibrinolysis GO:0042730 9.61 SERPINB2 SERPINE1
27 sprouting angiogenesis GO:0002040 9.61 ANGPT1 PGF TEK
28 vascular endothelial growth factor signaling pathway GO:0038084 9.57 FLT1 KDR
29 negative regulation of endothelial cell apoptotic process GO:2000352 9.56 ANGPT1 KDR SERPINE1 TEK
30 glomerulus vasculature development GO:0072012 9.5 ANGPT1 ANGPT2 TEK
31 positive regulation of angiogenesis GO:0045766 9.43 ANGPT2 FLT1 KDR PGF SERPINE1 TEK
32 Tie signaling pathway GO:0048014 9.33 ANGPT1 ANGPT2 TEK
33 angiogenesis GO:0001525 9.17 ANGPT1 ANGPT2 FLT1 KDR PGF SERPINE1
34 multicellular organism development GO:0007275 10.01 ANGPT1 ANGPT2 EGFR FLT1 KDR PGF

Molecular functions related to Placenta Accreta according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 kinase activity GO:0016301 9.76 EGFR FLT1 KDR TEK
2 protein kinase activity GO:0004672 9.73 EGFR FLT1 KDR TEK
3 receptor binding GO:0005102 9.67 ANGPT1 ANGPT2 EGFR SERPINE1
4 Ras guanyl-nucleotide exchange factor activity GO:0005088 9.58 ANGPT1 EGFR TEK
5 receptor tyrosine kinase binding GO:0030971 9.48 ANGPT1 ANGPT2
6 growth factor binding GO:0019838 9.33 FLT1 KDR TEK
7 signal transducer, downstream of receptor, with protein tyrosine kinase activity GO:0004716 9.32 EGFR KDR
8 vascular endothelial growth factor-activated receptor activity GO:0005021 9.26 FLT1 KDR
9 protein tyrosine kinase activity GO:0004713 9.26 EGFR FLT1 KDR TEK
10 transmembrane receptor protein tyrosine kinase activity GO:0004714 8.92 EGFR FLT1 KDR TEK

Sources for Placenta Accreta

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....